Melanoma dataset

<b>Dataset description</b>Study population: all incident cases of invasive cutaneous malignant melanoma (CMM) recorded in the Veneto Cancer Registry (Registro Tumori del Veneto – RTV) in 2015 (1,050 cases) and 2017 (1,205 cases) for which the number of mitoses was available.Study variables: sociodemographics (age and sex); clinico-pathological features (histological subtypes of CMM, tumor site, Breslow thickness, Clark level, CMM growth phase, ulceration, regression, tumor-infiltrating lymphocytes (TIL), mitotic count (number of mitoses per mm², T, N, and M AJCC stages at diagnosis (8th edition), and the number of positive lymph nodes after sentinel lymph node biopsy (SLNB)).CSV file legend:<b>ID_prog</b>subject unique identifier<b>age</b>age (in years) at CMM diagnosis<b>sex</b>"F" = female, "M" = male<b>year</b>year of diagnosis<b>histology</b>histological subtypes of CMM<b>site</b>primary tumor site<b>pT</b>AJCC (8th edition) T value<b>pN</b>AJCC (8th edition) N value<b>pM</b>AJCC (8th edition) M value<b>TNM_stage</b>AJCC (8th edition) TNM stage<b>breslow</b>Breslow thickness (in mm)<b>clark</b>Clark level<b>ulceration</b>presence of ulceration<b>regression</b>presence of regression<b>til</b>presence of tumor-infiltrating lymphocytes (TIL)<b>growth</b>CMM growth phase<b>positive_slnb</b>number of positive lymph nodes after sentinel lymph node biopsy (SLNB)<b>mitoses</b>number of mitoses per mm²<b>status</b>survival status (updated on December 31st, 2020): 0 = alive, 1 = dead<b>survival</b>follow-up time from CMM diagnosis (in days, updated on December 31st, 2020)<br>Correspondence to Claudia Cozzolino, Soft-Tissue, Peritoneum, and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV- IRCCS, Padova, Italy. E-mail: [e-mail]